HEADER TRANSFERASE 30-JAN-17 5MZ3 TITLE P38 ALPHA MUTANT C162S IN COMPLEX WITH CMPD2 [N-(4-METHYL-3-(4,4,5,5- TITLE 2 TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)-3-(TRIFLUOROMETHYL) TITLE 3 BENZAMIDE] COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 14,CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY DRUG-BINDING COMPND 5 PROTEIN,CSBP,MAP KINASE MXI2,MAX-INTERACTING PROTEIN 2,MITOGEN- COMPND 6 ACTIVATED PROTEIN KINASE P38 ALPHA,MAP KINASE P38 ALPHA,STRESS- COMPND 7 ACTIVATED PROTEIN KINASE 2A,SAPK2A; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS KINASE, INHIBITOR, PHOSPHOTRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.W.COWAN-JACOB,C.SCHEUFLER REVDAT 3 07-NOV-18 5MZ3 1 COMPND SOURCE REVDAT 2 29-NOV-17 5MZ3 1 JRNL REVDAT 1 15-NOV-17 5MZ3 0 JRNL AUTH A.SMITH,Z.J.NI,D.POON,Z.HUANG,Z.CHEN,Q.ZHANG,L.TANDESKE, JRNL AUTH 2 H.MERRITT,K.SHOEMAKER,J.CHAN,S.KAUFMAN,K.HUH,J.MURRAY, JRNL AUTH 3 B.A.APPLETON,S.W.COWAN-JACOB,C.SCHEUFLER,T.KANAZAWA, JRNL AUTH 4 J.M.JANSEN,D.STUART,C.M.SHAFER JRNL TITL IMIDAZO[1,2-A]PYRIDIN-6-YL-BENZAMIDE ANALOGS AS POTENT RAF JRNL TITL 2 INHIBITORS. JRNL REF BIOORG. MED. CHEM. LETT. V. 27 5221 2017 JRNL REFN ESSN 1464-3405 JRNL PMID 29107542 JRNL DOI 10.1016/J.BMCL.2017.10.047 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 28075 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1404 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.41 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2878 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2070 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2734 REMARK 3 BIN R VALUE (WORKING SET) : 0.2040 REMARK 3 BIN FREE R VALUE : 0.2530 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 144 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2793 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 279 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.15 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.41340 REMARK 3 B22 (A**2) : -0.97190 REMARK 3 B33 (A**2) : 2.38540 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.230 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.171 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.146 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.159 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.141 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2915 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3972 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1001 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 71 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 425 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2915 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 378 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3493 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.27 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.89 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -1.8722 -26.2188 21.8241 REMARK 3 T TENSOR REMARK 3 T11: -0.1067 T22: -0.0467 REMARK 3 T33: 0.0419 T12: 0.0315 REMARK 3 T13: -0.0269 T23: 0.0262 REMARK 3 L TENSOR REMARK 3 L11: 0.5253 L22: 0.5428 REMARK 3 L33: 0.7800 L12: 0.1421 REMARK 3 L13: -0.4138 L23: 0.0633 REMARK 3 S TENSOR REMARK 3 S11: -0.0212 S12: -0.0001 S13: -0.0415 REMARK 3 S21: 0.0313 S22: 0.0370 S23: -0.0018 REMARK 3 S31: -0.0045 S32: -0.0104 S33: -0.0158 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5MZ3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1200003293. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-AUG-07 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0063 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28075 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 26.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.780 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.86 REMARK 200 R MERGE FOR SHELL (I) : 0.47600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.510 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 19% PEG8000, 20MM MG ACETATE AND 0.1M REMARK 280 HEPES PH7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.95950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.73400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.80350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.73400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.95950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.80350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -8 REMARK 465 ALA A -7 REMARK 465 SER A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 4 CG CD OE1 OE2 REMARK 470 LYS A 15 CG CD CE NZ REMARK 470 LYS A 118 CG CD CE NZ REMARK 470 CYS A 119 SG REMARK 470 LYS A 121 CG CD CE NZ REMARK 470 HIS A 174 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 178 CG CD OE1 OE2 REMARK 470 LYS A 248 CD CE NZ REMARK 470 LEU A 353 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 57 68.79 38.21 REMARK 500 LYS A 118 -70.17 -55.36 REMARK 500 ARG A 149 -16.15 77.27 REMARK 500 PHE A 274 67.89 -104.54 REMARK 500 LEU A 289 58.60 -90.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8EN A 401 DBREF 5MZ3 A 1 360 UNP Q16539 MK14_HUMAN 1 360 SEQADV 5MZ3 MET A -8 UNP Q16539 INITIATING METHIONINE SEQADV 5MZ3 ALA A -7 UNP Q16539 EXPRESSION TAG SEQADV 5MZ3 SER A -6 UNP Q16539 EXPRESSION TAG SEQADV 5MZ3 HIS A -5 UNP Q16539 EXPRESSION TAG SEQADV 5MZ3 HIS A -4 UNP Q16539 EXPRESSION TAG SEQADV 5MZ3 HIS A -3 UNP Q16539 EXPRESSION TAG SEQADV 5MZ3 HIS A -2 UNP Q16539 EXPRESSION TAG SEQADV 5MZ3 HIS A -1 UNP Q16539 EXPRESSION TAG SEQADV 5MZ3 HIS A 0 UNP Q16539 EXPRESSION TAG SEQADV 5MZ3 SER A 162 UNP Q16539 CYS 162 ENGINEERED MUTATION SEQRES 1 A 369 MET ALA SER HIS HIS HIS HIS HIS HIS MET SER GLN GLU SEQRES 2 A 369 ARG PRO THR PHE TYR ARG GLN GLU LEU ASN LYS THR ILE SEQRES 3 A 369 TRP GLU VAL PRO GLU ARG TYR GLN ASN LEU SER PRO VAL SEQRES 4 A 369 GLY SER GLY ALA TYR GLY SER VAL CYS ALA ALA PHE ASP SEQRES 5 A 369 THR LYS THR GLY LEU ARG VAL ALA VAL LYS LYS LEU SER SEQRES 6 A 369 ARG PRO PHE GLN SER ILE ILE HIS ALA LYS ARG THR TYR SEQRES 7 A 369 ARG GLU LEU ARG LEU LEU LYS HIS MET LYS HIS GLU ASN SEQRES 8 A 369 VAL ILE GLY LEU LEU ASP VAL PHE THR PRO ALA ARG SER SEQRES 9 A 369 LEU GLU GLU PHE ASN ASP VAL TYR LEU VAL THR HIS LEU SEQRES 10 A 369 MET GLY ALA ASP LEU ASN ASN ILE VAL LYS CYS GLN LYS SEQRES 11 A 369 LEU THR ASP ASP HIS VAL GLN PHE LEU ILE TYR GLN ILE SEQRES 12 A 369 LEU ARG GLY LEU LYS TYR ILE HIS SER ALA ASP ILE ILE SEQRES 13 A 369 HIS ARG ASP LEU LYS PRO SER ASN LEU ALA VAL ASN GLU SEQRES 14 A 369 ASP SER GLU LEU LYS ILE LEU ASP PHE GLY LEU ALA ARG SEQRES 15 A 369 HIS THR ASP ASP GLU MET THR GLY TYR VAL ALA THR ARG SEQRES 16 A 369 TRP TYR ARG ALA PRO GLU ILE MET LEU ASN TRP MET HIS SEQRES 17 A 369 TYR ASN GLN THR VAL ASP ILE TRP SER VAL GLY CYS ILE SEQRES 18 A 369 MET ALA GLU LEU LEU THR GLY ARG THR LEU PHE PRO GLY SEQRES 19 A 369 THR ASP HIS ILE ASP GLN LEU LYS LEU ILE LEU ARG LEU SEQRES 20 A 369 VAL GLY THR PRO GLY ALA GLU LEU LEU LYS LYS ILE SER SEQRES 21 A 369 SER GLU SER ALA ARG ASN TYR ILE GLN SER LEU THR GLN SEQRES 22 A 369 MET PRO LYS MET ASN PHE ALA ASN VAL PHE ILE GLY ALA SEQRES 23 A 369 ASN PRO LEU ALA VAL ASP LEU LEU GLU LYS MET LEU VAL SEQRES 24 A 369 LEU ASP SER ASP LYS ARG ILE THR ALA ALA GLN ALA LEU SEQRES 25 A 369 ALA HIS ALA TYR PHE ALA GLN TYR HIS ASP PRO ASP ASP SEQRES 26 A 369 GLU PRO VAL ALA ASP PRO TYR ASP GLN SER PHE GLU SER SEQRES 27 A 369 ARG ASP LEU LEU ILE ASP GLU TRP LYS SER LEU THR TYR SEQRES 28 A 369 ASP GLU VAL ILE SER PHE VAL PRO PRO PRO LEU ASP GLN SEQRES 29 A 369 GLU GLU MET GLU SER HET 8EN A 401 33 HETNAM 8EN ~{N}-[3-(2-ACETAMIDOIMIDAZO[1,2-A]PYRIDIN-6-YL)-4- HETNAM 2 8EN METHYL-PHENYL]-3-(TRIFLUOROMETHYL)BENZAMIDE FORMUL 2 8EN C24 H19 F3 N4 O2 FORMUL 3 HOH *279(H2 O) HELIX 1 AA1 SER A 61 MET A 78 1 18 HELIX 2 AA2 ASP A 112 GLN A 120 1 9 HELIX 3 AA3 THR A 123 ALA A 144 1 22 HELIX 4 AA4 LYS A 152 SER A 154 5 3 HELIX 5 AA5 ASP A 176 THR A 180 5 5 HELIX 6 AA6 VAL A 183 TYR A 188 1 6 HELIX 7 AA7 ALA A 190 LEU A 195 1 6 HELIX 8 AA8 THR A 203 GLY A 219 1 17 HELIX 9 AA9 ASP A 227 GLY A 240 1 14 HELIX 10 AB1 GLY A 243 ILE A 250 1 8 HELIX 11 AB2 SER A 252 SER A 261 1 10 HELIX 12 AB3 ASN A 269 VAL A 273 5 5 HELIX 13 AB4 ASN A 278 LEU A 289 1 12 HELIX 14 AB5 ASP A 292 ARG A 296 5 5 HELIX 15 AB6 THR A 298 ALA A 304 1 7 HELIX 16 AB7 HIS A 305 ALA A 309 5 5 HELIX 17 AB8 ASP A 313 GLU A 317 5 5 HELIX 18 AB9 GLN A 325 ARG A 330 5 6 HELIX 19 AC1 LEU A 333 SER A 347 1 15 SHEET 1 AA1 2 PHE A 8 LEU A 13 0 SHEET 2 AA1 2 THR A 16 PRO A 21 -1 O TRP A 18 N GLN A 11 SHEET 1 AA2 5 TYR A 24 SER A 32 0 SHEET 2 AA2 5 GLY A 36 ASP A 43 -1 O VAL A 38 N GLY A 31 SHEET 3 AA2 5 LEU A 48 LEU A 55 -1 O VAL A 50 N ALA A 41 SHEET 4 AA2 5 TYR A 103 HIS A 107 -1 O LEU A 104 N LYS A 53 SHEET 5 AA2 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 AA3 2 LEU A 156 VAL A 158 0 SHEET 2 AA3 2 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 SITE 1 AC1 16 VAL A 38 ALA A 51 LYS A 53 GLU A 71 SITE 2 AC1 16 LEU A 74 LEU A 75 VAL A 83 ILE A 84 SITE 3 AC1 16 LEU A 104 THR A 106 LEU A 108 MET A 109 SITE 4 AC1 16 HIS A 148 LEU A 167 ASP A 168 PHE A 169 CRYST1 45.919 85.607 127.468 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021777 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011681 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007845 0.00000